Pharma company Invivyd, Inc. just announced it is working with the US Food and Drug Administration (FDA) on a pathway to rapid approval for a product it calls an “alternative” to COVID-19 vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results